BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
BUSINESS STRATEGY: Increase production capacity at Iowa facilities through physical expansion
using cutting-edge engineering design and integrating processing
technologies
Employ a regional approach to new ethanol production by focusing on port
sites and coastal urban areas on the Atlantic and Gulf coasts
Employ a sector strategy to expansion by focusing on the forests products
industry
AGREEMENTS: Name Products Content of Agreement Date
Aventine Xethanol products distribution
Forest Products
Laboratory
National
Renewable
Energy Laboratory
engineering of
genetically modified
yeasts to decrease
fermentation time of
feedstocks in the
production of ethanol
and/or xylitol
Clean Fractionation
technology
Queens University development of a
process to reduce the
time required to ferment
feedstock in the
Virginia
Polytechnic
Institute
production of ethanol
investigation of the
effect of newly
developed enzymes on
feedstocks
agreement
CRADA
research agreement
research agreement
research alliance
RESEARCH & DEVELOPMENT: Production of ethanol and related products using locally available biomass
rather than corn as the primary raw material
Yeda Research and Development Co. Ltd.
Weizmann Institute of Science, P.O. Box 95
Rehovot 76100, Israel
Phone: +972 8-947-0617; Fax: +972 8-947-0739
Web: www.yedarnd.com; E-mail: info.yeda@weizmann.ac.il
KEY PERSONNEL: Prof. Haim Garty; Chairman
Amir Naiberg.; CEO
Einat Zisman, Ph.D.; CBO
Ziv Hermon, Ph.D.; Sr. Licensing Officer
Noa Shelach, Ph.D.; Sr. Licensing Officer
Gil Granot-Mayer, Adv; General Counsel
Cohen Yaacov; CFO
Ruth Granoth, Ph.D.; Chief Intellectual Property Officer
EMPLOYEES: 17 employees
HISTORY: Founded in 1959
Member--Biotechnology Industry Organization
FACILITIES: Offices located at the Weizmann Institute of Science
STOCK-FINANCIAL HISTORY: Technology transfer entity
BUSINESS STRATEGY: Serve as a patent and licensing organization that acts as an intermediary
with industry and investors interested in licensing technologies from the
Weizmann Institute in return for commitment to develop the technologies
into products & payment of financial considerations to the Institute.
Copyright ©2006 AHC Media ® 391